How high will bcrx stock go
Web5 apr. 2024 · 9 Wall Street research analysts have issued twelve-month target prices for BioCryst Pharmaceuticals' stock. Their BCRX share … WebBCRX - BioCryst Pharmaceuticals, Inc. - Stock screener for investors and traders, financial visualizations. Home: News: Screener: Maps: Groups: Portfolio: Insider: ... Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks. Feb-08-23 07:34AM: BioCryst Pharmaceuticals (NASDAQ:BCRX) shareholders have earned a 54% CAGR over the last ...
How high will bcrx stock go
Did you know?
WebAbout Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. AMZN. +1.68 1.88%. Web10 mrt. 2024 · According to 18 stock analysts, the average 12-month stock price forecast for BCRX stock is $16.01, which predicts an increase of 93.12%. The lowest target is …
Web31 mrt. 2024 · Stock’s current price level is 5.77% above from estimated low price target while it is -253.36% below the estimated high; and even if the BCRX’s share succeeded to reach the median price of $13.00, then the outlook of -53.12% could come to the excitement of the investors. WebFind the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
WebBioCryst Pharmaceuticals, Inc. (BCRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Nasdaq +91.09(+0.76%) Russell 2000 +2.33(+0.13%) Crude Oil -0.24( … Web11 apr. 2024 · According to our research, BCRX stock is a acceptable long-term investment. BCRX share price has been in a positive cycle for the past year. BioCryst …
Web6 apr. 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were -$247.12 million, 34.3% more than in 2024. Financial Statements.
Web26 feb. 2024 · Analysts who follow BioCryst Pharmaceuticals, Inc. on average expect it to rise 268.09% over the next twelve months.Those same analysts give the stock an average rating of Strong Buy. That average rating puts BioCryst Pharmaceuticals, Inc. higher than 64 of stocks, based on data compiled by InvestorsObserver. how do you pronounce andy jassyWebBioCryst Pharmaceuticals, Inc. (BCRX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 8.68 +0.15 (+1.76%) At close: 04:00PM EDT 8.68 … how do you pronounce angelWebBCRX Stock 12 Months Forecast. Based on 8 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is $15.25 with a high … phone networks down ukWeb26 feb. 2024 · How High Does Wall Street Think BioCryst Pharmaceuticals, Inc. (BCRX) Stock Can Go? Analysts who follow BioCryst Pharmaceuticals, Inc. (BCRX) on average … phone network tfwWebBe the first to know when Wall Street analysts revise their BCRX stock forecasts and price targets. Get Free BCRX Updates. BCRX stock forecasts by analyst. All Analysts Top Analysts. ... the average BCRX price target is $17.20, with the highest BCRX stock price forecast at $30.00 and the lowest BCRX stock price forecast at $10.00. phone network in my areaWeb10 apr. 2024 · BioCryst Pharmaceuticals - BCRX - Stock Price Today - Zacks BioCryst Pharmaceuticals (BCRX) (Delayed Data from NSDQ) $8.53 USD +0.23 (2.77%) Updated Apr 5, 2024 04:00 PM ET After-Market:... how do you pronounce anencephalyWeb3 apr. 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 10.0. Learn More on BioCryst Pharmaceuticals's short interest ratio. how do you pronounce andromache